- Home
- TMCWW vs SNN Comparison
TMCWW vs SNN Comparison
Compare TMCWW & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TMCWW | SNN |
|---|---|---|
| Founded | 2011 | 1856 |
| Country | Canada | United Kingdom |
| Employees | 48 | 16988 |
| Industry | Metal Mining | Industrial Specialties |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 14.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TMCWW | SNN |
|---|---|---|
| Price | $0.28 | $30.61 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.25 |
| AVG Volume (30 Days) | 114.9K | ★ 1.1M |
| Earning Date | 03-24-2025 | 03-16-2026 |
| Dividend Yield | N/A | ★ 2.48% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.58 |
| Revenue Next Year | N/A | $5.60 |
| P/E Ratio | ★ N/A | $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.23 | $28.40 |
| 52 Week High | $3.84 | $38.79 |
Technical Indicators
Market Signals| Indicator | TMCWW | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 42.87 | 50.56 |
| Support Level | $0.24 | $29.08 |
| Resistance Level | $0.50 | $31.15 |
| Average True Range (ATR) | 0.05 | 0.51 |
| MACD | 0.00 | 0.14 |
| Stochastic Oscillator | 22.67 | 73.89 |
Price Performance
Historical ComparisonAbout TMCWW TMC the metals company Inc.
TMC The Metals Co Inc is a deep seabed minerals developer focused on the collection, processing and refining of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone (CCZ), approximately 1,500 miles (or 2,400 kilometers) south-west of San Diego, California. The company operates as a single operating and reportable segment, namely exploration of seafloor polymetallic nodules, which includes the development of a metallurgical process to treat such seafloor polymetallic nodules.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.